The FDA has proposed excluding semaglutide, tirzepatide, and liraglutide from a federal list used by some outsourcing compounders. If finalized, the change could narrow access to some compounded GLP-1 weight-loss products. The proposal does not change the approval status of brand-name obesity medicines. It does raise fresh questions about access, quality, and how compounded versions differ from FDA-approved drugs.
The FDA approved daily obesity pill orforglipron on April 1. Here is what its main placebo-controlled trial found, and what patients still do not know.
A knee arthritis study points to real symptom relief with semaglutide, but Medicare access still depends on why it is prescribed and who qualifies.
The FDA says some telehealth companies used false or misleading marketing for compounded GLP-1 drugs. Here is what that means for patients, how compounded products differ from approved drugs, and what to check before ordering online.
FDA has stepped up action against compounded GLP-1 weight-loss drugs sold online and through telehealth. Here’s what changed in 2026, why the agency says shortages no longer justify broad copycat compounding, what safety problems it has flagged, and how to protect yourself before buying.
New FDA-approved obesity medications have changed treatment options—but Medicare’s long-standing drug coverage rules still shape who can access them. Here’s what adults and families should understand in 2026 about eligibility, costs, and policy limits.
Ultra-processed foods are often blamed for rising rates of heart disease and diabetes. Here’s what the U.S. Dietary Guidelines and major studies actually show—what’s known, what’s uncertain, and what practical steps families can take.
A large randomized trial found that semaglutide reduced heart attacks and strokes in adults with overweight or obesity and established cardiovascular disease who did not have diabetes. Here’s what the evidence shows, what the FDA approval means, and what U.S. patients should know about safety, cost, and coverage.
The FDA has issued recent safety communications about compounded versions of popular GLP-1 drugs such as semaglutide and tirzepatide, warning of dosing errors, ingredient differences, and potential contamination. Here’s what patients and families should understand about the risks, legal limits, and how to protect themselves.
Federal regulators say current evidence does not show a clear link between GLP-1 weight-loss drugs and suicidal thoughts. Here’s what the FDA reviewed, what the data show, and what patients should watch for.
Obesity affects more than 2 in 5 U.S. adults and is linked to diabetes, heart disease, and other conditions. Here’s what current evidence says about screening, medications, lifestyle treatment, and what it means for families.
Arthritis affects millions of Americans and is a leading cause of disability. Here’s what the evidence shows about symptoms, treatment options, and practical steps that can help protect joint and overall health.
Cancer remains a leading cause of death in the United States, but prevention, screening, and treatment continue to improve. Here’s what current public health evidence shows—and what it means for individuals and families.
Federal health agencies continue to recommend at least 150 minutes of moderate physical activity each week for most adults. Here’s what that means in real life, who may need more (or less), and how fitness connects to overall health.
Heart disease remains the leading cause of death in the United States. Here’s what current public health data shows, who is most at risk, and what practical steps can help protect your heart.
New national data show 40.1 million people in the U.S. have diabetes, and updated 2026 care guidelines expand access to technology and obesity treatment. Here’s what that means for prevention, daily care, and long-term health.
Obesity remains a major public health concern in the United States. Here’s what current evidence shows about health risks, treatments, prevention, and what everyday families should understand.
This article explains how excess weight affects the body—from raising blood pressure, blood sugar, and cholesterol to increasing risks for heart disease, type 2 diabetes, stroke, sleep apnea, fatty liver disease, certain cancers, osteoarthritis, and fertility and mental health challenges. It breaks down the “why” behind these risks (inflammation, insulin resistance, and where fat is stored) in clear, patient-friendly terms and highlights early warning signs to discuss with a clinician. You’ll find practical steps that make a measurable difference—such as aiming for a modest 5–10% weight loss, improving nutrition and activity, prioritizing sleep and stress management, and considering medications or surgery when appropriate. The guide also lists key screenings to keep you safer, including blood pressure, A1C, lipids, and sleep apnea checks. Throughout, the tone is supportive and stigma-free, emphasizing that obesity is a medical condition with effective, evidence-based treatments and help available for patients and caregivers.
This article explains how obesity arises from a combination of genetics, lifestyle, and environment—showing that biology can influence appetite and metabolism, while factors like diet, physical activity, sleep, stress, medications, and access to healthy foods and safe spaces also play major roles. It emphasizes that obesity is a chronic, treatable condition—not a personal failure—and outlines evidence-based options including nutrition and activity changes, behavioral support, sleep and stress management, medications, and surgery when appropriate. Readers will gain clear, reliable guidance to reduce stigma, understand risk, and work with healthcare professionals on practical, personalized steps that make meaningful, sustainable progress.
This article distills the most reliable 2025 evidence into clear, doable steps for managing obesity with food and movement. It compares proven eating patterns—such as Mediterranean/DASH, higher‑protein lower‑refined‑carb, and plant‑forward plans—and shows how to build satisfying, budget‑friendly meals that emphasize protein, fiber, and minimally processed foods while honoring cultural preferences. It also outlines safe, scalable exercise plans that combine progressive strength training 2–3 days per week with 150–300+ minutes of moderate/vigorous activity and more daily steps, with adaptations for joint pain, low fitness, or limited time. Readers get practical guidance on goal‑setting, sleep and stress support, tracking, and community or digital tools, plus when to seek clinical help or pair lifestyle changes with medical treatments. The focus is on personalization, safety, and sustainable habits—offering patients and caregivers an encouraging roadmap that actually fits real life.
This article explains how obesity presents and is managed differently in children and adults, helping patients and caregivers make informed, compassionate choices. It outlines key distinctions in assessment (BMI-for-age percentiles in children vs. BMI in adults), growth and puberty considerations, and common health risks. You’ll learn why family-based lifestyle changes, supportive language, sleep and screen-time habits, and regular follow-up are central for children, while adults may benefit from structured programs, approved weight‑management medications, and, in some cases, surgery. The guide emphasizes mental health, stigma reduction, and culturally sensitive care, and clarifies when to seek medical evaluation and screening for related conditions. Practical, evidence-based steps and shared decision-making tips help families and adults find safe, effective, and sustainable treatment paths.
This article explains that while obesity is a chronic, relapsing condition, meaningful and lasting weight loss—and major improvements in health—are achievable with the right long-term plan. Doctors highlight a personalized approach that may combine nutrition and activity changes, sleep and stress management, behavioral therapy, FDA-approved weight-loss medications, and metabolic/bariatric surgery when appropriate. It emphasizes realistic goals, regular follow-up, and measuring success by health gains (like better blood sugar, blood pressure, liver health, mobility, and quality of life), not just the scale. For patients and caregivers, the key takeaway is that progress is possible with sustained support, team-based care, and compassion for setbacks along the way—partner with a healthcare professional to find the safest, most effective path for you.
End of content
End of content
